These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19689861)

  • 21. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
    Ingels H; Rasmussen J; Andersen PH; Harboe ZB; Glismann S; Konradsen H; Hoffmann S; Valentiner-Branth P; Lambertsen L;
    Vaccine; 2012 Jun; 30(26):3944-50. PubMed ID: 22504662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
    Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS
    Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and wales.
    Ladhani SN; Andrews NJ; Waight P; Borrow R; Slack MP; Miller E
    Clin Infect Dis; 2013 Mar; 56(5):633-40. PubMed ID: 23175560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.
    Adamkiewicz TV; Sarnaik S; Buchanan GR; Iyer RV; Miller ST; Pegelow CH; Rogers ZR; Vichinsky E; Elliott J; Facklam RR; O'Brien KL; Schwartz B; Van Beneden CA; Cannon MJ; Eckman JR; Keyserling H; Sullivan K; Wong WY; Wang WC
    J Pediatr; 2003 Oct; 143(4):438-44. PubMed ID: 14571216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive pneumococcal disease in Australia, 2006.
    Roche PW; Krause V; Cook H; Barralet J; Coleman D; Sweeny A; Fielding J; Giele C; Gilmour R; Holland R; Kampen R; ; Brown M; Gilbert L; Hogg G; Murphy D;
    Commun Dis Intell Q Rep; 2008 Mar; 32(1):18-30. PubMed ID: 18522302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive pneumococcal disease in Jamaican children.
    McGregor D; Barton M; Thomas S; Christie CD
    Ann Trop Paediatr; 2004 Mar; 24(1):33-40. PubMed ID: 15005964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.
    Yildirim I; Shea KM; Little BA; Silverio AL; Pelton SI;
    Pediatrics; 2015 Mar; 135(3):495-503. PubMed ID: 25647674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
    Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality.
    Harboe ZB; Dalby T; Weinberger DM; Benfield T; Mølbak K; Slotved HC; Suppli CH; Konradsen HB; Valentiner-Branth P
    Clin Infect Dis; 2014 Oct; 59(8):1066-73. PubMed ID: 25034421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
    Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
    dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
    Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumococcal vaccination rates in children with sickle cell disease.
    Nero AC; Akuete K; Leasure Reeves S; Dombkowski KJ
    J Public Health Manag Pract; 2014; 20(6):587-90. PubMed ID: 24253403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Missed opportunities in antipneumococcal vaccination. Can something more be done for prevention?
    Arencibia Jiménez M; Navarro Gracia JF; Delgado de Los Reyes JA; Pérez Torregrosa G; López Parra D; López García P
    Arch Bronconeumol; 2014 Mar; 50(3):93-8. PubMed ID: 24315186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease.
    Wagner AL; Shrivastwa N; Potter RC; Lyon-Callo SK; Boulton ML
    J Pediatr; 2018 May; 196():223-229. PubMed ID: 29555094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
    Johnson DR; D'Onise K; Holland RA; Raupach JC; Koehler AP
    Vaccine; 2012 Mar; 30(12):2206-11. PubMed ID: 22273663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compliance with intramuscular penicillin prophylaxis in children with sickle cell disease in Jamaica.
    King L; Ali S; Knight-Madden J; MooSang M; Reid M
    West Indian Med J; 2011 Mar; 60(2):177-80. PubMed ID: 21942123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective surveillance study of invasive pneumococcal disease among urban children in the Philippines.
    Capeding MR; Bravo L; Santos J; Kilgore PE; Kim SA; Balter I; Hubler R; Ye J; Moscariello M
    Pediatr Infect Dis J; 2013 Oct; 32(10):e383-9. PubMed ID: 23629024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.